» Articles » PMID: 38953012

The Association Between Triglyceride-Glucose Index and Its Combination with Obesity Indicators and Lower Extremity Peripheral Artery Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

Overview
Publisher Dove Medical Press
Specialty Endocrinology
Date 2024 Jul 2
PMID 38953012
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lower extremity peripheral artery disease (LEAD) is a significant chronic complication of type 2 diabetes mellitus (T2DM) that significantly contributes to disability and mortality. The subtle presentation of LEAD symptoms often leads to underrecognition and misdiagnosis. Therefore, identifying simple and effective evaluation indicators is essential for the early detection and management of LEAD. Insulin resistance is closely associated with diabetes and its complications. However, the specific relationship between insulin resistance-measured by the triglyceride-glucose (TyG) index-and obesity indicators in relation to LEAD remains unclear.

Objective: This study aims to investigate the association between the TyG index and its combination with obesity indicators in participants with T2DM and LEAD.

Methods: We performed a univariate analysis on 3176 T2DM patients to identify risk factors for LEAD. Patients were then divided into quartiles based on the TyG index combined with various obesity indicators. The chi-square test was used to compare the prevalence of LEAD across these groups. Logistic regression analysis was conducted to examine the association between the TyG index, in combination with different obesity indicators, and the occurrence of LEAD. Finally, we assessed the predictive ability of the TyG index combined with obesity indicators for LEAD by comparing the area under the ROC curve (AUC).

Results: The study included 3176 T2DM patients (1691 males and 1485 females) with a mean age of 56.16±10.60 years. Among them, 106 individuals had LEAD. The prevalence of LEAD varied significantly across quartiles of the TyG index, TyG-WC, and TyG-WHR (Q4 > Q3 > Q2 > Q1; P < 0.05). Multiple logistic regression analysis showed that the TyG index, TyG-WC, and TyG-WHR were positively associated with the risk of LEAD in T2DM patients. ROC curve analysis identified the best cutoff values for predicting LEAD: 9.8059 for the TyG index (sensitivity: 49.1%, specificity: 67.9%, AUC: 0.583), 808.8397 for TyG-WC (sensitivity: 70.8%, specificity: 47.8%, AUC: 0.603), and 8.8543 for TyG-WHR (sensitivity: 75.5%, specificity: 44.6%, AUC: 0.607).

Conclusion: In T2DM patients, the TyG index, TyG-WHR, and TyG-WC are positively associated with the occurrence of LEAD. TyG-WHR and TyG-WC exhibit a stronger correlation with LEAD compared to the TyG index alone, indicating their superior diagnostic value.

Citing Articles

The fibrosis-4 index and its association with carotid atherosclerosis in type 2 diabetes: a cross-sectional study in China.

Miao Y, Wang Y, Wan Q, Tong N BMC Cardiovasc Disord. 2025; 25(1):35.

PMID: 39833683 PMC: 11748503. DOI: 10.1186/s12872-025-04491-4.

References
1.
Aday A, Matsushita K . Epidemiology of Peripheral Artery Disease and Polyvascular Disease. Circ Res. 2021; 128(12):1818-1832. PMC: 8202714. DOI: 10.1161/CIRCRESAHA.121.318535. View

2.
Gao J, Hao Q, Gao M, Zhang K, Li X, Wang J . Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study. Cardiovasc Diabetol. 2021; 20(1):126. PMC: 8223290. DOI: 10.1186/s12933-021-01319-1. View

3.
Lim J, Kim J, Koo S, Kwon G . Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019; 14(3):e0212963. PMC: 6405083. DOI: 10.1371/journal.pone.0212963. View

4.
Love K, Liu Z . DPP4 Activity, Hyperinsulinemia, and Atherosclerosis. J Clin Endocrinol Metab. 2021; 106(6):1553-1565. PMC: 8118363. DOI: 10.1210/clinem/dgab078. View

5.
Rosengren A . Obesity and cardiovascular health: the size of the problem. Eur Heart J. 2021; 42(34):3404-3406. PMC: 8423455. DOI: 10.1093/eurheartj/ehab518. View